Reckitt Benckiser Group Stock Forecast for 2023 - 2025 - 2030
Updated on 04/26/2024
Reckitt Benckiser Group Stock Forecast and Price Target
Given the average yearlong price target of £54.00 provided by twelve prominent analysts over the past few months, there is a potential upside of approximately 23.97% from the last closing price in April, 2024 for Reckitt Benckiser Group's stock if it is reached. This estimation is based on a high estimate of £71.70 and a low estimate of £44.00. If you are interested in RKT stock, you should also look at its competitors.
23.97% Upside
Reckitt Benckiser Group Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Reckitt Benckiser Group's Price has seen a drop from £59.38 to £0.00 – a 100.00% decrease. In the next year, analysts expect Fair Value to reach £65.56 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MC Stock Forecast | LVMH Moët Hennessy - Louis Vu... | Outperform |
17
|
778.00€ | Buy/Sell | 775.72€ | 11.83% |
| PG Stock Forecast | Procter & Gamble | Outperform |
12
|
$162.55 | Buy/Sell | $166.80 | 6.08% |
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$146.82 | Buy/Sell | $174.55 | 15.79% |
| MRK Stock Forecast | Merck | Outperform |
2
|
$130.72 | Buy/Sell | $130.51 | 7.10% |
| KO Stock Forecast | Coca Cola | Outperform |
18
|
$61.74 | Buy/Sell | $65.84 | 6.90% |
Reckitt Benckiser Group Revenue Forecast for 2023 - 2025 - 2030
Reckitt Benckiser Group's Revenue has increased by 4.39% In the last three years, going from £13.99B to £14.61B. In the next year, analysts expect Revenue to reach £15.33B – an increase of 4.95%. For the next seven years, the forecast is for Revenue to grow by 36.06%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| OR Stock Forecast | L'Oréal | Hold |
18
|
435.75€ | Buy/Sell | 419.40€ | 3.27% |
| AZN Stock Forecast | AstraZeneca PLC | Outperform |
17
|
£120.26 | Buy/Sell | £165.99 | 34.72% |
| NOVN Stock Forecast | Novartis | Hold |
10
|
CHF90.00 | Buy/Sell | CHF105.00 | 19.58% |
.jpg)
Reckitt Benckiser Group Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Reckitt Benckiser Group's Dividend per Share has grown, increasing from £1.75 to £1.93 – a growth of 10.29%. The next year looks promising for Reckitt Benckiser Group, with analysts predicting Dividend per Share of £2.00 – an increase of 3.63%. Over the next seven years, experts anticipate that Reckitt Benckiser Group's Dividend per Share will grow at a rate of 17.28%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PFE Stock Forecast | Pfizer | Outperform |
2
|
$25.26 | Buy/Sell | $32.87 | 20.74% |
| SAN Stock Forecast | Sanofi | Outperform |
16
|
91.62€ | Buy/Sell | 102.80€ | 18.97% |
| REGN Stock Forecast | Regeneron Pharmaceuticals | Outperform |
2
|
$890.68 | Buy/Sell | $961.26 | 17.89% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MDLZ Stock Forecast | Mondelez International | Buy |
15
|
$70.80 | Buy/Sell | $83.21 | 15.82% |
| GSK Stock Forecast | GSK | Outperform |
12
|
£16.41 | Buy/Sell | £17.30 | 18.83% |
| SHW Stock Forecast | Sherwin Williams | Outperform |
15
|
$304.81 | Buy/Sell | $317.38 | 11.37% |
Reckitt Benckiser Group EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Reckitt Benckiser Group's EBITDA has grown from £3.48B to £4.56B – a 31.03% increase. In the following year, 17 experts forecast that Reckitt Benckiser Group's EBITDA will decrease by 9.28%, to £4.14B. Over the next seven years, the forecast is for EBITDA to grow by 20.24%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MO Stock Forecast | Altria Group Inc | Hold |
5
|
$43.54 | Buy/Sell | $46.90 | 3.35% |
| CL Stock Forecast | Colgate-Palmolive Co | Outperform |
18
|
$89.29 | Buy/Sell | $88.97 | 4.16% |
| 500696 Stock Forecast | Hindustan Unilever | Outperform |
10
|
Rp2.23k | Buy/Sell | Rp2.75k | 14.14% |
Reckitt Benckiser Group EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Reckitt Benckiser Group's EBIT has grown by 6.49%, rising from £3.15B to £3.35B. For next year, analysts predict EBIT of £3.65B, which would mean an increase of 9.07%. Over the next seven years, experts predict that Reckitt Benckiser Group's EBIT will grow at a rate of 29.08%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ECL Stock Forecast | Ecolab | Hold |
18
|
$219.79 | Buy/Sell | $205.36 | 5.10% |
| EL Stock Forecast | Estee Lauder Cos Inc-The | Outperform |
18
|
$144.99 | Buy/Sell | $138.34 | 9.25% |
| KER Stock Forecast | Kering | Hold |
14
|
327.30€ | Buy/Sell | 621.06€ | 10.75% |
Reckitt Benckiser Group EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Reckitt Benckiser Group's EPS has seen a drop from £3.27 to £0.00 – a 100.00% decrease. In the next year, analysts expect EPS to reach £3.61 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| KMB Stock Forecast | Kimberly-Clark | Hold |
18
|
$136.43 | Buy/Sell | $128.04 | -0.32% |
| LONN Stock Forecast | Lonza Group | Buy |
16
|
CHF513.80 | Buy/Sell | CHF516.89 | 13.86% |
| BN Stock Forecast | Danone | Outperform |
11
|
59.30€ | Buy/Sell | 55.47€ | 7.93% |
Site Navigation
.jpg)